These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
594 related articles for article (PubMed ID: 26852737)
41. Transcriptionally Active Lung Microbiome and Its Association with Bacterial Biomass and Host Inflammatory Status. Ren L; Zhang R; Rao J; Xiao Y; Zhang Z; Yang B; Cao D; Zhong H; Ning P; Shang Y; Li M; Gao Z; Wang J mSystems; 2018; 3(5):. PubMed ID: 30417108 [TBL] [Abstract][Full Text] [Related]
42. Association of sputum microbiome with clinical outcome of initial antibiotic treatment in hospitalized patients with acute exacerbations of COPD. Liu H; Zheng D; Lin Y; Liu Z; Liang Z; Su J; Chen R; Zhou H; Wang Z Pharmacol Res; 2020 Oct; 160():105095. PubMed ID: 32730904 [TBL] [Abstract][Full Text] [Related]
43. Lung microbiology and exacerbations in COPD. Beasley V; Joshi PV; Singanayagam A; Molyneaux PL; Johnston SL; Mallia P Int J Chron Obstruct Pulmon Dis; 2012; 7():555-69. PubMed ID: 22969296 [TBL] [Abstract][Full Text] [Related]
45. Analysis of the airway microbiota of healthy individuals and patients with chronic obstructive pulmonary disease by T-RFLP and clone sequencing. Zakharkina T; Heinzel E; Koczulla RA; Greulich T; Rentz K; Pauling JK; Baumbach J; Herrmann M; Grünewald C; Dienemann H; von Müller L; Bals R PLoS One; 2013; 8(7):e68302. PubMed ID: 23874580 [TBL] [Abstract][Full Text] [Related]
46. Immunology, genetics and microbiota in the COPD pathophysiology: potential scope for patient stratification. Malhotra R; Olsson H Expert Rev Respir Med; 2015 Apr; 9(2):153-9. PubMed ID: 25586213 [TBL] [Abstract][Full Text] [Related]
47. Comparative analysis of the alveolar microbiome in COPD, ECOPD, Sarcoidosis, and ILD patients to identify respiratory illnesses specific microbial signatures. Gupta S; Shariff M; Chaturvedi G; Sharma A; Goel N; Yadav M; Mortensen MS; Sørensen SJ; Mukerji M; Chauhan NS Sci Rep; 2021 Feb; 11(1):3963. PubMed ID: 33597669 [TBL] [Abstract][Full Text] [Related]
48. Characterization of throat microbial flora in smokers with or without COPD. Diao W; Shen N; Du Y; Qian K; He B Int J Chron Obstruct Pulmon Dis; 2017; 12():1933-1946. PubMed ID: 28740374 [TBL] [Abstract][Full Text] [Related]
49. Acute exacerbations of COPD: risk factors for failure and relapse. Mantero M; Rogliani P; Di Pasquale M; Polverino E; Crisafulli E; Guerrero M; Gramegna A; Cazzola M; Blasi F Int J Chron Obstruct Pulmon Dis; 2017; 12():2687-2693. PubMed ID: 28932112 [TBL] [Abstract][Full Text] [Related]
50. Comprehensive profiling of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity. Chiu YC; Lee SW; Liu CW; Lin RC; Huang YC; Lan TY; Wu LS PLoS One; 2021; 16(4):e0249944. PubMed ID: 33836012 [TBL] [Abstract][Full Text] [Related]
51. Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease. Diao W; Shen N; Du Y; Erb-Downward JR; Sun X; Guo C; Ke Q; Huffnagle GB; Gyetko MR; He B Int J Chron Obstruct Pulmon Dis; 2018; 13():2289-2299. PubMed ID: 30104869 [TBL] [Abstract][Full Text] [Related]
52. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. Huang YJ; Kim E; Cox MJ; Brodie EL; Brown R; Wiener-Kronish JP; Lynch SV OMICS; 2010 Feb; 14(1):9-59. PubMed ID: 20141328 [TBL] [Abstract][Full Text] [Related]
53. Targeting respiratory microbiomes in COPD and bronchiectasis. Mac Aogáin M; Tiew PY; Jaggi TK; Narayana JK; Singh S; Hansbro PM; Segal LN; Chotirmall SH Expert Rev Respir Med; 2024; 18(3-4):111-125. PubMed ID: 38743428 [TBL] [Abstract][Full Text] [Related]
54. Microbiome in Chronic Obstructive Pulmonary Disease: Role of Natural Products Against Microbial Pathogens. Santoro A; Tomino C; Prinzi G; Cardaci V; Fini M; Macera L; Russo P; Maggi F Curr Med Chem; 2020; 27(18):2931-2948. PubMed ID: 31838985 [TBL] [Abstract][Full Text] [Related]